Total Funding
$51.5M
Employee Range
11-50
GPN Vaccines develops vaccines to prevent the spread of streptococcus pneumoniae. Their innovative approach aims to protect individuals from this harmful bacteria, enhancing public health worldwide.
GPN Vaccines data powered by:
Share
GPN Vaccines data powered by:
GPN VaccinesOverall Ranking
Regional Rank
Share
Loading...
In Australia and Oceania
Top null%out of startups
GPN VaccinesIndustry Rankings in
Healthtech
City Rank
Share
2nd
In Adelaide
Top 19%out of 11 startups
National Rank
Share
46th
In Australia
Top 21%out of 229 startups
Regional Rank
Share
49th
In Australia and Oceania
Top 19%out of 270 startups
GPN VaccinesSubindustry Rankings in
BiotechnologyCity Rank
Share
1st
In Adelaide
Top 25%out of 4 startups
National Rank
Share
8th
In Australia
Top 14%out of 59 startups
Regional Rank
Share
9th
In Australia and Oceania
Top 12%out of 76 startups
rankings by:
GPN VaccinesSB Rank Evolution
Not enough data points to display the chart.
GPN VaccinesstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro